Trial Profile
EP4-receptor Antagonism and Prostaglandin E2 (PGE2) in a Human Headache Model.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs AP 1531 (Primary)
- Indications Headache
- Focus Therapeutic Use
- 10 Jan 2011 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 10 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Oct 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.